D'Haens G - Search Results

1

Emerging therapies for ulcerative colitis.

Hanzel J, Hulshoff MS, Grootjans J, D'Haens G. Hanzel J, et al. Expert Rev Clin Immunol. 2022 May;18(5):513-524. doi: 10.1080/1744666X.2022.2069562. Epub 2022 May 1. Expert Rev Clin Immunol. 2022. PMID: 35477319 Review.

2

Optimizing biologic therapies for inflammatory bowel disease (ulcerative colitis and Crohn's disease).

Ferrante M, D'Haens G, Rutgeerts P, Vermeire S, Van Assche G. Ferrante M, et al. Curr Gastroenterol Rep. 2009 Dec;11(6):504-8. doi: 10.1007/s11894-009-0076-5. Curr Gastroenterol Rep. 2009. PMID: 19903427 Review.

3

Current misunderstandings in the management of ulcerative colitis.

Ochsenkühn T, D'Haens G. Ochsenkühn T, et al. Gut. 2011 Sep;60(9):1294-9. doi: 10.1136/gut.2010.218180. Epub 2011 Apr 19. Gut. 2011. PMID: 21504997 Free article. Review.

4

The effect of appendectomy on the course of ulcerative colitis: a systematic review.

Gardenbroek TJ, Eshuis EJ, Ponsioen CI, Ubbink DT, D'Haens GR, Bemelman WA. Gardenbroek TJ, et al. Colorectal Dis. 2012 May;14(5):545-53. doi: 10.1111/j.1463-1318.2011.02600.x. Colorectal Dis. 2012. PMID: 21689293 Review.

5

Once-daily MMX(®) mesalamine for endoscopic maintenance of remission of ulcerative colitis.

D'Haens G, Sandborn WJ, Barrett K, Hodgson I, Streck P. D'Haens G, et al. Am J Gastroenterol. 2012 Jul;107(7):1064-77. doi: 10.1038/ajg.2012.103. Epub 2012 May 8. Am J Gastroenterol. 2012. PMID: 22565161 Clinical Trial.

6

The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis.

Feagan BG, Sandborn WJ, D'Haens G, Pola S, McDonald JWD, Rutgeerts P, Munkholm P, Mittmann U, King D, Wong CJ, Zou G, Donner A, Shackelton LM, Gilgen D, Nelson S, Vandervoort MK, Fahmy M, Loftus EV Jr, Panaccione R, Travis SP, Van Assche GA, Vermeire S, Levesque BG. Feagan BG, et al. Gastroenterology. 2013 Jul;145(1):149-157.e2. doi: 10.1053/j.gastro.2013.03.025. Epub 2013 Mar 22. Gastroenterology. 2013. PMID: 23528626 Clinical Trial.

7

Histologic evaluation of ulcerative colitis: a systematic review of disease activity indices.

Mosli MH, Feagan BG, Sandborn WJ, Dʼhaens G, Behling C, Kaplan K, Driman DK, Shackelton LM, Baker KA, Macdonald JK, Vandervoort MK, Geboes K, Levesque BG. Mosli MH, et al. Inflamm Bowel Dis. 2014 Mar;20(3):564-75. doi: 10.1097/01.MIB.0000437986.00190.71. Inflamm Bowel Dis. 2014. PMID: 24412993 Review.

8

Meijs S, Gardenbroek TJ, Sprangers MA, Bemelman WA, Buskens CJ, D'Haens GR, Löwenberg M. Meijs S, et al. J Crohns Colitis. 2014 Jul;8(7):686-92. doi: 10.1016/j.crohns.2013.12.011. Epub 2014 Jan 11. J Crohns Colitis. 2014. PMID: 24418659

9

Vedolizumab for the treatment of ulcerative colitis.

Rietdijk ST, D'Haens GR. Rietdijk ST, et al. Expert Rev Clin Pharmacol. 2014 Jul;7(4):423-30. doi: 10.1586/17512433.2014.911084. Epub 2014 May 6. Expert Rev Clin Pharmacol. 2014. PMID: 24802046 Review.

10

A systematic review of the measurement of endoscopic healing in ulcerative colitis clinical trials: recommendations and implications for future research.

Samaan MA, Mosli MH, Sandborn WJ, Feagan BG, DʼHaens GR, Dubcenco E, Baker KA, Levesque BG. Samaan MA, et al. Inflamm Bowel Dis. 2014 Aug;20(8):1465-71. doi: 10.1097/MIB.0000000000000046. Inflamm Bowel Dis. 2014. PMID: 24831558 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

599 results

Search Page